The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease
Open accessAbstract
Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,564
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Self-citationFusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
A new subtype of frontotemporal lobar degeneration with FUS pathology
Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H. A., & Mackenzie, I. R. A. (2009) · Brain · doi:10.1093/brain/awp214 · Cited by 722
Self-citationRethinking ALS: The FUS about TDP-43
Lagier-Tourenne, C., & Cleveland, D. W. (2009) · Cell · doi:10.1016/j.cell.2009.03.006 · Cited by 588
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0460-5 · Cited by 418
Self-citationTLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1741 · Cited by 350
Andersson, M. K., Ståhlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., Stenman, G., Nilsson, O., & Åman, P. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-37 · Cited by 345
Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., Nishikawa, T., Hicks, G. G., & Takumi, T. (2005) · Current Biology · doi:10.1016/j.cub.2005.01.058 · Cited by 322
TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines
Fujii, R., & Takumi, T. (2005) · Journal of Cell Science · doi:10.1242/jcs.02692 · Cited by 247
Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA Splicing
Yang, L., Embree, L. J., Tsai, S., & Hickstein, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27761 · Cited by 224
TLS, EWS and TAF15: a model for transcriptional integration of gene expression
Law, W. J. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell015 · Cited by 200
Neurofilaments and neurological disease
Al‐Chalabi, A., & Miller, C. C. J. (2003) · BioEssays · doi:10.1002/bies.10251 · Cited by 189
Neurofilament proteins in neurodegenerative diseases
Liu, Q., Xie, F., Siedlak, S. L., Nunomura, A., Honda, K., Moreira, P. I., Zhua, X., Smith, M. A., & Perry, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4268-8 · Cited by 172
Neurofilament inclusion body disease: a new proteinopathy?
Josephs, K. A., Holton, J. L., Rossor, M. N., Braendgaard, H., Ozawa, T., Fox, N. C., Petersen, R. C., Pearl, G. S., Ganguly, M., Rosa, P., et al. (2003) · Brain · doi:10.1093/brain/awg231 · Cited by 172
Baechtold, H., Kuroda, M., Sok, J., Ron, D., Lopez, B. S., & Akhmedov, A. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34337 · Cited by 171
Expression Patterns of the Human Sarcoma-Associated GenesFUSandEWSand the Genomic Structure ofFUS
Åman, P., Panagopoulos, I., Lassen, C., Fioretos, T., Mencinger, M., Toresson, H., Höglund, M., Forster, A., Rabbitts, T. H., Ron, D., et al. (1996) · Genomics · doi:10.1006/geno.1996.0513 · Cited by 166
Mackenzie, I. R., Foti, D. J., Woulfe, J., & Hurwitz, T. A. (2008) · Brain · doi:10.1093/brain/awn061 · Cited by 161
Self-citationClinical and neuropathologic variation in neuronal intermediate filament inclusion disease
Cairns, N. J., Grossman, M., Arnold, S. E., Burn, D. J., Jaros, E., Perry, R. H., Duyckaerts, C., Stankoff, B., Pillon, B., Skullerud, K., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000139809.16817.dd · Cited by 160
Self-citationPerrotti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski, T., Salomoni, P., Grassilli, E., Iozzo, R. V., Cooper, D. R., & Calabretta, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4442 · Cited by 132
Cairns, N. J., Zhukareva, V. A., Uryu, K., Zhang, B., Bigio, E. H., Mackenzie, I. R., Gearing, M., Duyckaerts, C. J., Yokoo, H., Nakazato, Y., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63773-x · Cited by 123
Self-citationDoi, H., Okamura, K., Bauer, P. O., Furukawa, Y., Shimizu, H., Kurosawa, M., Machida, Y., Miyazaki, H., Mitsui, K., Kuroiwa, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705306200 · Cited by 119
Bertrand, P., Akhmedov, A. T., Delacôte, F., Dürrbach, A., & López, B. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203048 · Cited by 99
TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD
Roeber, S., Mackenzie, I. R., Kretzschmar, H. A., & Neumann, M. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0395-x · Cited by 95
Self-citationBigio, E. H., Lipton, A. M., White, C. L., Dickson, D. W., & Hirano, A. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00466.x · Cited by 90
Update on the Neuropathological Diagnosis of Frontotemporal Dementias
Trojanowski, J. Q., & Dickson, D. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1123 · Cited by 89
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions
Cairns, N. J., Perry, R. H., Jaros, E., Burn, D. J., McKeith, I. G., Lowe, J. S., Holton, J. L., Rossor, M. N., Skullerud, K., Duyckaerts, C. J., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00100-9 · Cited by 83
Yokota, O., Tsuchiya, K., Terada, S., Ishizu, H., Uchikado, H., Ikeda, M., Oyanagi, K., Nakano, I., Murayama, S., Kuroda, S., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0329-z · Cited by 78
Cairns, N., Uryu, K., Bigio, E. H., Mackenzie, I. R., Gearing, M., Duyckaerts, C. J., Yokoo, H., Nakazato, Y., Jaros, E., Perry, R., et al. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0882-7 · Cited by 63
Self-citationMackenzie, I. R., & Feldman, H. (2004) · PubMed · Cited by 44
Self-citationExtending the clinicopathological spectrum of neurofilament inclusion disease
Josephs, K. A., Uchikado, H., McComb, R. D., Bashir, R. M., Wszołek, Z. K., Swanson, J. W., Matsumoto, J. Y., Shaw, G., & Dickson, D. W. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0974-4 · Cited by 32
Clinical and Pathological Heterogeneity of Neuronal Intermediate Filament Inclusion Disease
Molina‐Porcel, L., Lladó, A., Rey, M. J., Molinuevo, J. L., Martinez‐Lage, M., Esteve, F. X., Ferrer, I., TOLOSA, E. S., & Blesa, R. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.37 · Cited by 29
Mosaheb, S., Thorpe, J. R., Hashemzadeh‐Bonehi, L., Bigio, E. H., Gearing, M., & Cairns, N. J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1057-x · Cited by 23
Heterogeneous inclusions in neurofilament inclusion disease
Uchikado, H., Li, A., Lin, W., & Dickson, D. W. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00709.x · Cited by 21
Cited by
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012
Self-citationTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Self-citationALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import
Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R. A., Capell, A., Schmid, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.143 · Cited by 836
Self-citationClinical, genetic and pathological heterogeneity of frontotemporal dementia: A review
Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.212225 · Cited by 609
Metadata
- Authors
- Neumann, M., Roeber, S., Kretzschmar, H. A., Rademakers, R., Baker, M., & Mackenzie, I. R. A.
- Venue
- Acta Neuropathologica
- Published
- 2009-08-09
- Volume
- 118
- Issue
- 5
- Pages
- 605-616
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2172179321
- Cited by
- 257
- References
- 36
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.